Back to Search Start Over

Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies.

Authors :
Fumiaki Imamura
Amanda M Fretts
Matti Marklund
Andres V Ardisson Korat
Wei-Sin Yang
Maria Lankinen
Waqas Qureshi
Catherine Helmer
Tzu-An Chen
Jyrki K Virtanen
Kerry Wong
Julie K Bassett
Rachel Murphy
Nathan Tintle
Chaoyu Ian Yu
Ingeborg A Brouwer
Kuo-Liong Chien
Yun-Yu Chen
Alexis C Wood
Liana C Del Gobbo
Luc Djousse
Johanna M Geleijnse
Graham G Giles
Janette de Goede
Vilmundur Gudnason
William S Harris
Allison Hodge
Frank Hu
InterAct Consortium
Albert Koulman
Markku Laakso
Lars Lind
Hung-Ju Lin
Barbara McKnight
Kalina Rajaobelina
Ulf Riserus
Jennifer G Robinson
Cecilia Samieri
Mackenzie Senn
David S Siscovick
Sabita S Soedamah-Muthu
Nona Sotoodehnia
Qi Sun
Michael Y Tsai
Tomi-Pekka Tuomainen
Matti Uusitupa
Lynne E Wagenknecht
Nick J Wareham
Jason H Y Wu
Renata Micha
Rozenn N Lemaitre
Dariush Mozaffarian
Nita G Forouhi
Source :
PLoS Medicine, Vol 17, Iss 6, p e1003102 (2020)
Publication Year :
2020
Publisher :
Public Library of Science (PLoS), 2020.

Abstract

BackgroundDe novo lipogenesis (DNL) is the primary metabolic pathway synthesizing fatty acids from carbohydrates, protein, or alcohol. Our aim was to examine associations of in vivo levels of selected fatty acids (16:0, 16:1n7, 18:0, 18:1n9) in DNL with incidence of type 2 diabetes (T2D).Methods and findingsSeventeen cohorts from 12 countries (7 from Europe, 7 from the United States, 1 from Australia, 1 from Taiwan; baseline years = 1970-1973 to 2006-2010) conducted harmonized individual-level analyses of associations of DNL-related fatty acids with incident T2D. In total, we evaluated 65,225 participants (mean ages = 52.3-75.5 years; % women = 20.4%-62.3% in 12 cohorts recruiting both sexes) and 15,383 incident cases of T2D over the 9-year follow-up on average. Cohort-specific association of each of 16:0, 16:1n7, 18:0, and 18:1n9 with incident T2D was estimated, adjusted for demographic factors, socioeconomic characteristics, alcohol, smoking, physical activity, dyslipidemia, hypertension, menopausal status, and adiposity. Cohort-specific associations were meta-analyzed with an inverse-variance-weighted approach. Each of the 4 fatty acids positively related to incident T2D. Relative risks (RRs) per cohort-specific range between midpoints of the top and bottom quintiles of fatty acid concentrations were 1.53 (1.41-1.66; p < 0.001) for 16:0, 1.40 (1.33-1.48; p < 0.001) for 16:1n-7, 1.14 (1.05-1.22; p = 0.001) for 18:0, and 1.16 (1.07-1.25; p < 0.001) for 18:1n9. Heterogeneity was seen across cohorts (I2 = 51.1%-73.1% for each fatty acid) but not explained by lipid fractions and global geographical regions. Further adjusted for triglycerides (and 16:0 when appropriate) to evaluate associations independent of overall DNL, the associations remained significant for 16:0, 16:1n7, and 18:0 but were attenuated for 18:1n9 (RR = 1.03, 95% confidence interval (CI) = 0.94-1.13). These findings had limitations in potential reverse causation and residual confounding by imprecisely measured or unmeasured factors.ConclusionsConcentrations of fatty acids in the DNL were positively associated with T2D incidence. Our findings support further work to investigate a possible role of DNL and individual fatty acids in the development of T2D.

Subjects

Subjects :
Medicine

Details

Language :
English
ISSN :
15491277 and 15491676
Volume :
17
Issue :
6
Database :
Directory of Open Access Journals
Journal :
PLoS Medicine
Publication Type :
Academic Journal
Accession number :
edsdoj.8b4202118eac4cb5818ea8b4e67c2043
Document Type :
article
Full Text :
https://doi.org/10.1371/journal.pmed.1003102